Effects of pitavastatin add-on therapy on chronic kidney disease with albuminuria and dyslipidemia

BACKGROUND: In non-dialysis chronic kidney disease (CKD) patients with dyslipidemia, statin therapy is recommended to prevent cardiovascular complications. Dyslipidemia has been also shown to be an independent risk factor for the progression of CKD. However, it is still unclear whether statin therap...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Lipids Health Dis
Glavni autori: Ohsawa, Masato, Tamura, Kouichi, Wakui, Hiromichi, Kanaoka, Tomohiko, Azushima, Kengo, Uneda, Kazushi, Haku, Sona, Kobayashi, Ryu, Ohki, Kohji, Haruhara, Kotaro, Kinguchi, Sho, Toya, Yoshiyuki, Umemura, Satoshi
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2015
Teme:
Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4673714/
https://ncbi.nlm.nih.gov/pubmed/26645467
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12944-015-0164-5
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items